Biotech Finds Mid-Week Success Following Q4 Earnings Release
13 Marzo 2024 - 2:25PM
AllPennyStocks.com
A California-based biotech company saw its
shares soar on Wednesday, a day following the company’s Q4 earnings
announcement. With analysts expecting a net loss of $0.16
per...
To read the full story on AllPennyStocks.com, click
here.
Heron Therapeautics (NASDAQ:HRTX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Heron Therapeautics (NASDAQ:HRTX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024